Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1958 3
1959 1
1961 1
1964 1
1965 2
1966 2
1967 1
1968 3
1970 2
1971 1
1972 4
1973 3
1974 2
1975 3
1976 2
1977 4
1978 2
1979 4
1980 4
1981 6
1982 6
1983 7
1984 11
1985 7
1986 11
1987 8
1988 8
1989 19
1990 12
1991 15
1992 14
1993 25
1994 24
1995 28
1996 40
1997 36
1998 44
1999 45
2000 43
2001 43
2002 72
2003 93
2004 121
2005 148
2006 153
2007 192
2008 224
2009 270
2010 321
2011 347
2012 431
2013 492
2014 634
2015 659
2016 670
2017 758
2018 809
2019 948
2020 1109
2021 1284
2022 1499
2023 1441
2024 1583
2025 1826
2026 612

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,455 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chen l[au] (102,333 results)?
Netarsudil-associated conjunctival fragility.
Vongsachang H, Davtyan E, Lin MM, Shen LQ, Margeta MA. Vongsachang H, et al. Among authors: shen lq. Am J Ophthalmol Case Rep. 2026 Jan 29;41:102533. doi: 10.1016/j.ajoc.2026.102533. eCollection 2026 Mar. Am J Ophthalmol Case Rep. 2026. PMID: 41675443 Free PMC article.
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.
Peng Z, Zhang Y, Xu H, Yang Y, Yang M, Zhang M, Cheng Y, Chen X, Pan Y, Wang F, Li Q, Xu N, Liu L, Gu K, Xiao J, Zhang R, Zhao Q, Chen J, Lin L, Chen Y, Deng Y, Cai S, Bai B, Wang Y, Shen L. Peng Z, et al. Among authors: shen l. BMJ. 2026 Mar 12;392:e086115. doi: 10.1136/bmj-2025-086115. BMJ. 2026. PMID: 41819560 Free PMC article. Clinical Trial.
Anacardic acid mitigates post‑MI cardiac fibrosis via suppressing p38/JNK-GATA3 pathway and H3K9ac‑dependent epigenetic regulation.
Huang W, Wang X, Yan X, Wang S, Lin L, Li L, Liu L, Wang Y, Li X, Mao Y, Liu X, Chen Y, Kong J, Shen L, Jiang Q, Li R, Li H, Zhang J, Zhang R, Wang F, Sun X, Guo Y, Jiang W. Huang W, et al. Among authors: shen l. Phytomedicine. 2026 Feb;151:157783. doi: 10.1016/j.phymed.2026.157783. Epub 2026 Jan 6. Phytomedicine. 2026. PMID: 41518994
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models.
Shen L, Chen Z, Xu J, He Q, Zhang C, Zhou X, Ding X, Fang J, Li F, Jiao M, Yang Y, Dong B, Wan L, Ding X, Zheng Y, Zhou J, Zuo C, Min T, Zhu M, Ma B, Wan Y, Guo Q, Zhang H, Hua J, Wang P, Li Q, Long J, Song X, Zhang Y. Shen L, et al. J Clin Invest. 2026 Jan 13;136(5):e196613. doi: 10.1172/JCI196613. eCollection 2026 Mar 2. J Clin Invest. 2026. PMID: 41528883 Free PMC article.
Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.
Huang Y, Sun D, Zhou H, Zhou T, Qu S, Li J, Hu C, Xu M, Li W, Shen L, Wu H, Lang J, Hu G, Luo Z, Fu Z, Qu S, Feng W, Chen X, Lin S, Xie B, Li X, Sun Y, Lin Z, Lin Q, Lei F, Long J, Hong J, Huang X, Zeng L, Wang P, He X, Zhao S, Chen G, Zhang Y, Zhao Y, Fang W, Huang C, Li X, Hong S, Zhang L, Yang Y. Huang Y, et al. Among authors: shen l. JAMA Oncol. 2026 Mar 1;12(3):295-302. doi: 10.1001/jamaoncol.2025.6245. JAMA Oncol. 2026. PMID: 41609753 Free PMC article. Clinical Trial.
15,455 results
You have reached the last available page of results. Please see the User Guide for more information.